NYSE:MED MEDIFAST (MED) Stock Price, News & Analysis $14.10 +0.53 (+3.91%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About MEDIFAST Stock (NYSE:MED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MEDIFAST alerts:Sign Up Key Stats Today's Range$13.52▼$14.2550-Day Range$12.03▼$14.1752-Week Range$11.57▼$22.66Volume177,467 shsAverage Volume242,270 shsMarket Capitalization$154.96 millionP/E RatioN/ADividend YieldN/APrice Target$16.50Consensus RatingHold Company OverviewMedifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.Read More… MEDIFAST Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks68th Percentile Overall ScoreMED MarketRank™: MEDIFAST scored higher than 68% of companies evaluated by MarketBeat, and ranked 78th out of 152 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingMEDIFAST has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageMEDIFAST has received no research coverage in the past 90 days.Read more about MEDIFAST's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth200.00% Earnings GrowthEarnings for MEDIFAST are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MEDIFAST is -21.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of MEDIFAST is -21.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMEDIFAST has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about MEDIFAST's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.65% of the float of MEDIFAST has been sold short.Short Interest Ratio / Days to CoverMEDIFAST has a short interest ratio ("days to cover") of 6.8.Change versus previous monthShort interest in MEDIFAST has recently increased by 24.06%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMEDIFAST does not currently pay a dividend.Dividend GrowthMEDIFAST does not have a long track record of dividend growth. Sustainability and ESG2.0 / 5Environmental Score-4.00 Percentage of Shares Shorted15.65% of the float of MEDIFAST has been sold short.Short Interest Ratio / Days to CoverMEDIFAST has a short interest ratio ("days to cover") of 6.8.Change versus previous monthShort interest in MEDIFAST has recently increased by 24.06%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News SentimentN/A Search Interest1 people have searched for MED on MarketBeat in the last 30 days. MarketBeat Follows1 people have added MEDIFAST to their MarketBeat watchlist in the last 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, MEDIFAST insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.90% of the stock of MEDIFAST is held by insiders.Percentage Held by Institutions95.51% of the stock of MEDIFAST is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MEDIFAST's insider trading history. Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MEDIFAST and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Stock News Headlines5 Revealing Analyst Questions From Medifast’s Q1 Earnings CallJune 23, 2025 | msn.comMedifast Stockholders Approve Key Proposals at Annual MeetingJune 20, 2025 | tipranks.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.June 30 at 2:00 AM | Brownstone Research (Ad)2 Cash-Heavy Stocks to Keep an Eye On and 1 to IgnoreJune 17, 2025 | finance.yahoo.comIs Medifast Gaining or Losing Market Support?June 13, 2025 | benzinga.com1 Safe-and-Steady Stock on Our Watchlist and 2 to QuestionJune 13, 2025 | msn.comMondelez (MDLZ) Down 2.2% Since Last Earnings Report: Can It Rebound?May 30, 2025 | msn.comPersonal Care Stocks Q1 In Review: Medifast (NYSE:MED) Vs PeersMay 27, 2025 | msn.comSee More Headlines MED Stock Analysis - Frequently Asked Questions How have MED shares performed this year? MEDIFAST's stock was trading at $17.62 at the beginning of the year. Since then, MED stock has decreased by 20.0% and is now trading at $14.10. View the best growth stocks for 2025 here. How were MEDIFAST's earnings last quarter? MEDIFAST INC (NYSE:MED) posted its quarterly earnings results on Monday, April, 28th. The specialty retailer reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.07) by $0.04. The specialty retailer had revenue of $115.73 million for the quarter, compared to the consensus estimate of $114.85 million. MEDIFAST had a negative net margin of 1.29% and a positive trailing twelve-month return on equity of 6.63%. Read the conference call transcript. How do I buy shares of MEDIFAST? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MEDIFAST own? Based on aggregate information from My MarketBeat watchlists, some other companies that MEDIFAST investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY). Company Calendar Last Earnings4/28/2025Today6/30/2025Next Earnings (Estimated)8/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry FOOD - MISC/DIVERSIFIED Sub-IndustryPersonal Products Current SymbolNYSE:MED CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees870Year FoundedN/APrice Target and Rating Average Stock Price Target$16.50 High Stock Price Target$16.50 Low Stock Price Target$16.50 Potential Upside/Downside+17.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.65) Trailing P/E RatioN/A Forward P/E Ratio27.65 P/E GrowthN/ANet Income$2.09 million Net Margins-1.29% Pretax Margin-1.34% Return on Equity6.63% Return on Assets4.81% Debt Debt-to-Equity RatioN/A Current Ratio3.52 Quick Ratio2.87 Sales & Book Value Annual Sales$602.46 million Price / Sales0.26 Cash Flow$3.05 per share Price / Cash Flow4.62 Book Value$19.21 per share Price / Book0.73Miscellaneous Outstanding Shares10,990,000Free Float10,672,000Market Cap$154.96 million OptionableOptionable Beta0.88 Social Links 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:MED) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredConsumer apocalypse imminent (7 ominous red flags)The #1 Gold play right now (not a miner, ETF, or bullion) Gold is up 237% since 2008... but one gold invest...Stansberry Research | Sponsored“Trump’s 24-Hour Profit Windows” revealedTrading legend Larry Benedict has discovered a repeating surge of $240 billion (and more)... Flowing into a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEDIFAST INC Please log in to your account or sign up in order to add this asset to your watchlist. Share MEDIFAST With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.